$15.510
+0.090 (+0.58%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RCEL por análisis de gráficos similares
Alphio's RCEL stock price prediction model matches the current AVITA Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.41 (-0.67%). The 1-week path is $15.79 (+1.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de AVITA Medical Inc?
AVITA Medical Inc. (RCEL) appears to be a good buy right now due to its current price of $15.51, which is well below the analyst price target of $15, suggesting a potential upside. The stock has shown impressive performance with a year-to-date change of +346.97% and a 5-day change of +18.94%, indicating strong momentum. However, the main risk is the negative net income, which was -$7.66 million in Q2 2026, highlighting ongoing financial challenges that investors should consider.
RCEL cerró en $15.51 el Friday, tras subir +0.58%
AVITA Medical Inc (RCEL) last closed at $15.51, gaining +0.58%. These facts feed the 1-day and 1-week RCEL price prediction above.
Factores de la previsión
Los factores de la previsión de AVITA Medical Inc (RCEL) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RCEL, ordenadas por similitud.
Análisis de estacionalidad de RCEL
Historically the probability of a positive October return for RCEL is 26.98%. February offers the highest probability of a positive month at 67.24%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RCEL
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $7.01 | $8.29 | $10.48 | -46.56% |
| Nov 2026 | $8.42 | $10.39 | $12.31 | -33.04% |
| Dec 2026 | $8.53 | $9.10 | $9.30 | -41.34% |
En 2026, se proyecta que AVITA Medical Inc (RCEL) oscile entre $7.01 y $12.31.
Previsión mensual de AVITA Medical Inc para 2026
En Oct de 2026, se proyecta que AVITA Medical Inc promedie $8.29, con un mínimo de $7.01 y un máximo de $10.48.
En Nov de 2026, se proyecta que AVITA Medical Inc promedie $10.39, con un mínimo de $8.42 y un máximo de $12.31.
En Dec de 2026, se proyecta que AVITA Medical Inc promedie $9.10, con un mínimo de $8.53 y un máximo de $9.30.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.